Literature DB >> 16809941

Expression of Oct4, a stem cell marker, in the hamster pancreatic cancer model.

Katsumichi Iki1, Parviz M Pour.   

Abstract

BACKGROUND: Oct4 has been shown to present a stem cell marker that is expressed in embryonic cells and in germ cell tumors. Recently, its expression in a few human tissues and cancer cells has been reported. Because in the hamster pancreatic cancer model most tumors develop from within islets presumably from stem cells, we investigated the expression of Oct4 in this model.
METHODS: Two normal pancreases and 15 pancreatic cancers induced by N-nitrosobis(2-oxypropyl)amine (BOP) were processed for immunohistochemistry using a monoclonal Oct4 antibody at a concentration of 1:500.
RESULTS: In the normal pancreas, Oct4 was expressed only in islet cells in a diffuse cytoplasmic pattern. No nuclear staining was found in any cells. In 14 of the pancreatic cancers, nuclear staining was detected in many cells or in small foci. Diffuse cytoplasmic but no nuclear staining was found in one tumor and a mixed Golgi type and nuclear staining in two cases. Nuclear staining was also identified in early intrainsular ductular and in Ca in situ lesions.
CONCLUSIONS: BOP reactivates the Oct4 gene and can be considered an early tumor marker in this model. Copyright (c) 2006 S. Karger AG, Basel and IAP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16809941     DOI: 10.1159/000094317

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  10 in total

1.  MiR-335 functions as a tumor suppressor in pancreatic cancer by targeting OCT4.

Authors:  Ling Gao; Yijin Yang; Haiyan Xu; Ruqian Liu; Dechun Li; Han Hong; Mingde Qin; Yunliang Wang
Journal:  Tumour Biol       Date:  2014-05-24

2.  Expression of OCT4 in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis.

Authors:  Wei He; Ke Li; Feng Wang; Yan-Ru Qin; Qing-Xia Fan
Journal:  World J Gastroenterol       Date:  2012-02-21       Impact factor: 5.742

3.  OCT4 pseudogenes present in human leukemia cells.

Authors:  Xiaoping Guo; Yongmin Tang
Journal:  Clin Exp Med       Date:  2011-11-16       Impact factor: 3.984

4.  Downregulation of the transcription factor, FoxD3, is associated with lymph node metastases in invasive ductal carcinomas of the breast.

Authors:  Hua Zhao; Daozhen Chen; Jiayuan Wang; Yongxiang Yin; Qiong Gao; Ye Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

5.  Expression of transcription factor Oct4 in bladder cancer cell line T24 and its effects on the biological characteristics of the cells.

Authors:  Zhiqiang Zhu; Jianguo Wen; Xiangyu Zheng; Daoxie Wang; Qingwei Wang; Changhui Fan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-02-18

6.  New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster.

Authors:  J F Spencer; J E Sagartz; W S M Wold; K Toth
Journal:  Cancer Gene Ther       Date:  2009-05-29       Impact factor: 5.987

Review 7.  Octamer-binding transcription factors: genomics and functions.

Authors:  Feng-Qi Zhao
Journal:  Front Biosci (Landmark Ed)       Date:  2013-06-01

8.  Chronic cadmium exposure in vitro causes acquisition of multiple tumor cell characteristics in human pancreatic epithelial cells.

Authors:  Wei Qu; Erik J Tokar; Andrew J Kim; Matthew W Bell; Michael P Waalkes
Journal:  Environ Health Perspect       Date:  2012-05-24       Impact factor: 9.031

9.  OCT4 expression and vasculogenic mimicry formation positively correlate with poor prognosis in human breast cancer.

Authors:  Tieju Liu; Baocun Sun; Xiulan Zhao; Yanlei Li; Qiang Gu; Xueyi Dong; Fang Liu
Journal:  Int J Mol Sci       Date:  2014-10-28       Impact factor: 5.923

10.  Follicle-stimulating hormone inhibits apoptosis in ovarian cancer cells by regulating the OCT4 stem cell signaling pathway.

Authors:  Zhenbo Zhang; Yaping Zhu; Yunli Lai; Xiaomei Wu; Zhengzhong Feng; Yinhua Yu; Robert C Bast; Xiaoping Wan; Xiaowei Xi; Youji Feng
Journal:  Int J Oncol       Date:  2013-08-06       Impact factor: 5.650

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.